alanyl-glutamyl-aspartyl-glycine has been researched along with delta sleep-inducing peptide in 1 studies
| Studies (alanyl-glutamyl-aspartyl-glycine) | Trials (alanyl-glutamyl-aspartyl-glycine) | Recent Studies (post-2010) (alanyl-glutamyl-aspartyl-glycine) | Studies (delta sleep-inducing peptide) | Trials (delta sleep-inducing peptide) | Recent Studies (post-2010) (delta sleep-inducing peptide) |
|---|---|---|---|---|---|
| 181 | 8 | 28 | 467 | 19 | 22 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anisimov, VN; Khavinson, VKh | 1 |
1 review(s) available for alanyl-glutamyl-aspartyl-glycine and delta sleep-inducing peptide
| Article | Year |
|---|---|
[The use of peptide bioregulators for cancer prevention: results of 35 years of research experience and perspectives].
Topics: Aging; Animals; Antineoplastic Agents; Delta Sleep-Inducing Peptide; Dipeptides; Humans; Mice; Neoplasms; Neuropeptides; Neurotransmitter Agents; Oligopeptides; Rats | 2009 |